Between Standardisation and Flexibility. Defining Granularity of the eCTD Module 3.2.S for Different Types of Drug Substances in Europe
Developing a Companion Diagnostics in parallel to a medicinal product. Legal and Regulatory requirements in Europe and in the US
3,5 Jahre ATMP Verordnung und nur eine erfolgreiche Zulassungbei der EMA!